I am not sure that the COVID-19 track will bring anything meaningful - I could well be wrong but there seems to be no pointers to success in this area.
Nothing will replace a vaccine - and BIT is not chasing that - more of something to alleviate symptoms. MERCK is basically developing a cold and flu medication - with the benefits of clearing air ways and an inflammatory plus a pain suppressor.
Given that simple solution then we have to ask what BIT is doing in the field.
I still say that HIV/HepC is BITs forte and they should concentrate their efforts in that area. Having unrealistic expectations that BIT will have a huge breakthrough with OID-19 may just bring about disappointment.
Know I am not being very optimistic with COV-19 and will upset some here - sorry about that.
I am not sure that the COVID-19 track will bring anything...
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
0.001(1.79%) |
Mkt cap ! $53.23M | |||
| Open | High | Low | Value | Volume |
| 5.9¢ | 6.0¢ | 5.6¢ | $13.16K | 233.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 420774 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.9¢ | 71841 | 3 |
View Market Depth
| Last trade - 15.13pm 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.6¢ |
Change
0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 5.9¢ | 6.0¢ | 5.6¢ | 133857 | ||
| Last updated 12.10pm 15/05/2024 ? | |||||
| BIT (ASX) Chart |